Sanofi (SNY) Reports Q2 EPS of EUR1.59; offers guidance

Sanofi (NASDAQ: SNY) reported Q2 EPS of EUR1.59. Revenue for the quarter came in at EUR9.99 billion.

GUIDANCE

In 2025, sales are anticipated to grow by a high single-digit percentage at CER (previously mid-to-high single-digit). Sanofi confirms the expectation of a strong business EPS rebound with growth at a low double-digit percentage at CER (before share buyback), now including all expenses from newly acquired businesses4

Sanofi intends to complete its €5 billion share buyback program in 2025. 80.3% has been repurchased to date

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders